These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17925599)

  • 1. Hospital admissions for Guillain-Barré syndrome in the United States, 1993-2004.
    Frenzen PD
    Neuroepidemiology; 2007; 29(1-2):83-8. PubMed ID: 17925599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome: incidence and mortality rates in US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    Neurology; 2008 Apr; 70(18):1608-13. PubMed ID: 18443311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
    Iqbal S; Li R; Gargiullo P; Vellozzi C
    Vaccine; 2015 Apr; 33(17):2045-9. PubMed ID: 25749247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome in northwest Greece.
    Markoula S; Giannopoulos S; Sarmas I; Tzavidi S; Kyritsis AP; Lagos G
    Acta Neurol Scand; 2007 Mar; 115(3):167-73. PubMed ID: 17295711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
    Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features.
    França MC; Deus-Silva L; de Castro R; Garibaldi SG; Pfeilsticker BH; Nucci A; Marques JF
    Arq Neuropsiquiatr; 2005 Sep; 63(3B):772-5. PubMed ID: 16258654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in outcomes for hospitalized injured patients.
    Mullins RJ; Diggs BS; Hedges JR; Newgard CD; Arthur M; Adams AL; Veum-Stone J; Lenfesty B; Trunkey DD
    J Trauma; 2006 Apr; 60(4):691-8; discussion 699-700. PubMed ID: 16612288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
    J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmapheresis in Guillain-Barre syndrome].
    Carbajal-Ramírez A; Castañón-González JA; Osvaldo-Talavera J; de la Torre-Nieto ML; León-Gutiérrez MA
    Gac Med Mex; 2002; 138(6):527-31. PubMed ID: 12532617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
    Seta T; Nagayama H; Katsura K; Hamamoto M; Araki T; Yokochi M; Utsumi K; Katayama Y
    Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996.
    Bogliun G; Beghi E;
    Acta Neurol Scand; 2004 Aug; 110(2):100-6. PubMed ID: 15242417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital discharge database optimization in Guillain-Barré syndrome surveillance.
    Lee CD; Jones TF
    Muscle Nerve; 2012 Jul; 46(1):60-2. PubMed ID: 22644597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous immunoglobulin therapy for Guillain-Barré syndrome in Japan: changes in treatment after its inclusion in health insurance coverage].
    Nishimoto Y; Yuki N
    Rinsho Shinkeigaku; 2004 Sep; 44(9):633-5. PubMed ID: 15515710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).
    Shui IM; Rett MD; Weintraub E; Marcy M; Amato AA; Sheikh SI; Ho D; Lee GM; Yih WK;
    Neuroepidemiology; 2012; 39(2):109-15. PubMed ID: 22846726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.
    Holman RC; Belay ED; Christensen KY; Folkema AM; Steiner CA; Schonberger LB
    Pediatr Infect Dis J; 2010 Jun; 29(6):483-8. PubMed ID: 20104198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unintentional pediatric submersion-injury-related hospitalizations in the United States, 2003.
    Cohen RH; Matter KC; Sinclair SA; Smith GA; Xiang H
    Inj Prev; 2008 Apr; 14(2):131-5. PubMed ID: 18388235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.